Research To Practice | Oncology Videos
by Dr Neil Love
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇧🇷BR · Science#1711K to 10K
- 🇹🇷TR · Science#139500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
450 to 3.9K🎙 Daily cadence·863 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
1.5K to 13K🇧🇷77%🇹🇷23% - Active Followers
Loyal subscribers who consistently listen
450 to 3.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jul 22, 2026
1h 57m 57s
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jul 20, 2026
1h 29m 57s
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
Jul 18, 2026
46m 28s
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy (Companion Faculty Lecture)
Jul 17, 2026
30m 12s
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Jul 16, 2026
1h 58m 27s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/22/26 | EGFR-Mutated Non-Small Cell Lung CancerFirst-Line Treatment+4 | Dr Sarah B GoldbergDr Jonathan Goldman+2 | ASCO | — | EGFRNon-Small Cell Lung Cancer+5 | — | 1h 57m 57s | ||
| 7/20/26 | Endometrial CancerChemoimmunotherapy+3 | Dr Floor J BackesDr Brian M Slomovitz | — | — | Endometrial CancerChemoimmunotherapy+5 | — | 1h 29m 57s | ||
| 7/18/26 | HER2-positive metastatic breast cancerfirst-line therapy+5 | Prof Dr Sibylle Loibl | trastuzumab deruxtecanpertuzumab | — | HER2-positivemetastatic breast cancer+8 | — | 46m 28s | ||
| 7/17/26 | HER2-positive metastatic breast cancerfirst-line treatment+5 | Prof Dr Sibylle Loibl | trastuzumab deruxtecanpertuzumab+5 | — | HER2-positivemetastatic breast cancer+6 | — | 30m 12s | ||
| 7/16/26 | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 | Dr Farrukh T AwanMs Robin Klebig+1 | CD20 x CD3 Bispecific AntibodiesPolatuzumab Vedotin+7 | — | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+5 | — | 1h 58m 27s | ||
| 7/15/26 | Ovarian CancerPARP Inhibitors+4 | Dr Ramez N EskanderDr Ursula Matulonis+2 | — | — | Ovarian CancerPARP Inhibitors+5 | — | 2h 01m 19s | ||
| 7/14/26 | HER2-mutant lung cancermetastatic cancer+3 | Dr Mark JengDr Joshua K Sabari | zongertinib | NSCLC | HER2non-small cell lung cancer+5 | — | 27m 32s | ||
| 7/13/26 | HR-Positive Breast CancerAdjuvant Treatment+4 | Dr Harold J BursteinDr Joyce O'Shaughnessy | — | — | breast canceradjuvant therapy+4 | — | 58m 12s | ||
| 7/13/26 | breast cancerHR-positive+4 | Joyce O'Shaughnessy, MD | Research To PracticeCME | — | localized breast cancerHR-positive+5 | — | 38m 35s | ||
| 7/13/26 | Localized HR-Positive Breast CancerEndocrine Therapy+3 | Harold J Burstein, MD, PhD | — | — | breast cancerHR-positive+5 | — | 27m 44s |
Showing 10 of 10
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Research To Practice | Oncology Videos
Peaked at #139 in TR, currently #139 in TR.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TR | — | #139 | #139 | — |
| Brazil | — | #171 | #171 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.